| abstract |
(57) Abstract: A novel monocyclic L-nucleoside compound represented by the general formula (I). Embodiments of these compounds include infection, parasite infestation, It is believed to be useful in treating a variety of diseases, including neoplasms and autoimmune diseases. Regarding the mechanism and embodiment of the novel compound, immunomodulatory activity has been observed, and Th1 and Th1 It is expected to be useful in modulating cytokine patterns, including modulating two responses. Embedded image |